CVE-2022-45611
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated...
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
- Record
CVE-2022-45611- CVSS 3.1
- 9.8 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-522
- Updated
- 2026-11-02
CVE List No score
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
- Record
CVE-2022-45611- Updated
- 2026-11-02
EUVDEUVD-2022-48475 No score
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
- Record
EUVD-2022-48475- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-7qc3-f88f-rqhv
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated...
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
- Record
GHSA-7qc3-f88f-rqhv- CVSS 3.1
- 9.8 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-522
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-45611 is a critical vulnerability (CVSS 9.8) in Fresenius-kabi Pharmahelp Firmware, published August 22, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.18%, the 67th percentile. No source names a fixed version.